Clinical Image

References

1. ↵
   1. Northrup H,
   2. Krueger DA,
   3. the International Tuberous Sclerosis Complex Consensus Group

   (2013) Tuberous Sclerosis Complex Diagnostic Criteria Update: Recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference. Pediatr Neurol 49, 243–254.
2. ↵
   1. Major P

   (2011) Potential of mTOR inhibitors for the treatment of subependymal giant cell astrocytomas in tuberous sclerosis complex. Aging (Albany NY) 3, 189–191.
3. ↵
   1. Benito AE,
   2. Arreguin FE,
   3. Almazan BO,
   4. Baà Âos EJ,
   5. Navarro BM,
   6. Carbajal JF

   (2016) Subependymal giant cell astrocytoma in pediatric patients with tuberous sclerosis complex treated with mTOR inhibitors: One center experience. Journal of Clinical Oncology 34, e22001–e22001.